The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study.

MLA

Nishiyama, Naotaka, et al. “The Neutrophil-Lymphocyte Ratio Has a Role in Predicting the Effectiveness of Nivolumab in Japanese Patients with Metastatic Renal Cell Carcinoma: A Multi-Institutional Retrospective Study.” BMC Urology, vol. 20, no. 1, July 2020, p. 110. EBSCOhost, https://doi.org/10.1186/s12894-020-00679-2.

APA

Nishiyama, N., Hirobe, M., Kikushima, T., Matsuki, M., Takahashi, A., Yanase, M., Ichimatsu, K., Egawa, M., Hayashi, N., Negishi, T., Masumori, N., & Kitamura, H. (2020). The neutrophil-lymphocyte ratio has a role in predicting the effectiveness of nivolumab in Japanese patients with metastatic renal cell carcinoma: a multi-institutional retrospective study. BMC Urology, 20(1), 110. https://doi.org/10.1186/s12894-020-00679-2

Chicago

Nishiyama, Naotaka, Megumi Hirobe, Takuya Kikushima, Masahiro Matsuki, Atsushi Takahashi, Masahiro Yanase, Keisuke Ichimatsu, et al. 2020. “The Neutrophil-Lymphocyte Ratio Has a Role in Predicting the Effectiveness of Nivolumab in Japanese Patients with Metastatic Renal Cell Carcinoma: A Multi-Institutional Retrospective Study.” BMC Urology 20 (1): 110. doi:10.1186/s12894-020-00679-2.